nations benefit from high volume of cross-border trades in goods and services. As Cambodia continues to grow rapidly, Cambodian capital market will definitely soon become an engine of growth for the Kingdom
transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65
) Customer – Most of NDR in Thailand and Malaysia respectively. FKRMM has 4 warehouses to distribute goods to more than 79 distributors in Malaysia. Therefore, this business acquisition is the opportunity of
take-home products. Executive Summary 2 Overall Operating Results of the Company in Q3/2020 Q3/19 Q3/20 9M/19 9M/20 Change +/(-) (THB million) YoY 9M Operating Revenue 312 198 (37%) 911 561 (38%) Gross
greater proportion than the reduction in costs of sales, which includes fixed expenses. In addition, the proportion of take-home products, which have a higher average cost than sit-in products, increased in
%. Revenue from production cosmetic products was THB 21.74 Million having decrease by 12.11%. Revenue from network marketing business was THB 79.49 Million having growth by 77.74% The revenue of each
changes in the types of products produced or services rendered; name changes; or the nature and results of any bankruptcy, receivership or similar proceedings with respect to the issuer or significant
10.06% as compared to 2016. However, higher proportion of cost of sales to net revenues from sales increased from 48.69% to 49.08% as a result of increasing prices of goods and raw materials including
due to the effect of an annual selling price adjustment, a change in foreign currency exchange rate and an increase in the cost of goods sold resulting from a continuously high cost of raw materials
increasing in cost of goods sold of 36% and increasing in selling expenses of 10% Financial results of 3-month ended period Unit: million baht for 3-month period ended March Detail 2018 2017 diff % Total